Ossifying fibromyxoid tumour
| Ossifying fibromyxoid tumour | |
|---|---|
| Synonyms | OFMT |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Painless, slow-growing mass |
| Complications | Rarely metastasizes |
| Onset | Typically in adulthood |
| Duration | Chronic |
| Types | Classic, atypical, malignant |
| Causes | Unknown |
| Risks | Possible genetic predisposition |
| Diagnosis | Histopathology, immunohistochemistry |
| Differential diagnosis | Soft tissue sarcoma, fibroma, myxoma |
| Prevention | None known |
| Treatment | Surgical excision |
| Medication | None specific |
| Prognosis | Generally good, but depends on type |
| Frequency | Rare |
| Deaths | N/A |
Ossifying fibromyxoid tumour (OFMT) is a rare and distinct type of soft tissue tumour that was first described in 1989. It is characterized by a combination of fibrous, myxoid, and ossifying components. The tumour is usually benign, but in rare cases, it can be malignant.
Clinical Presentation[edit]
Patients with OFMT often present with a slow-growing, painless mass. The tumour is most commonly found in the deep soft tissues of the extremities, particularly the thigh, but it can also occur in the trunk, head, and neck. The age of patients at the time of diagnosis ranges from 15 to 83 years, with a median age of 50 years. There is a slight male predominance.
Pathology[edit]
Histologically, OFMT is characterized by a lobulated growth pattern with a fibrous pseudocapsule. The tumour cells are small and round to spindle-shaped, with a moderate amount of eosinophilic cytoplasm. The nuclei are round to oval and have a finely granular chromatin pattern. The tumour stroma varies from fibrous to myxoid, and there is often a peripheral rim of metaplastic bone.
Diagnosis[edit]
The diagnosis of OFMT is based on the characteristic histological features, but it can be challenging due to the rarity of the tumour and its histological overlap with other soft tissue tumours. Immunohistochemistry can be helpful in the diagnosis. The tumour cells are usually positive for vimentin, S-100 protein, and CD34, and negative for desmin and smooth muscle actin.
Treatment and Prognosis[edit]
The treatment of choice for OFMT is surgical excision with clear margins. The prognosis is generally good, with a low rate of local recurrence and distant metastasis. However, malignant cases can have a more aggressive course.
See Also[edit]
References[edit]
<references />
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian

